Anlon Healthcare Limited announced that its shareholders have approved key changes to the company's Memorandum of Association (MOA) through a postal ballot on April 08, 2026. These approvals, based on the outcome of a Board Meeting held on March 06, 2026, and the Scrutinizer's Report dated April 08, 2026, include the alteration of the capital clause subsequent to the sub-division of equity shares. The company's authorized share capital was previously ₹55,00,00,000 (Rupees Fifty-Five Crores) divided into 5,50,00,000 (Five Crore Fifty Lacs) equity shares of ₹10/- each. Following the sub-division, the authorized share capital remains ₹55,00,00,000 (Rupees Fifty-Five Crores), but it will now be divided into 27,50,00,000 (Twenty-Seven Crore Fifty Lakh) equity shares of ₹02/- each. Additionally, shareholders approved an increase in the authorized share capital. The capital clause of the MOA has been altered to reflect an authorized share capital of ₹1,10,00,00,000 (Rupees One Hundred and Ten Crores), divided into 55,00,00,000 (Fifty-Five Crore) equity shares of ₹2/- each. These resolutions were passed as Special Resolutions.
